← Eichor
Study identifier: NCT05829317 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Condition: Critical Illness · New Onset Atrial Fibrillation  ·  Sponsor: Dr. Stephanie Sibley

PhasePhase 4
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A double-blind, multi-centre, randomized, placebo-controlled, feasibility pilot trial in the prevention of new onset atrial fibrillation of critically ill patients admitted to an ICU.

This description comes directly from the study's public registry record.

Talk to the study team

Miranda Hunt  ·  613 549 6666  ·  miranda.hunt@kingstonhsc.ca

Always discuss trial participation with your own doctor first.

Locations (4)

St Joseph's Healthcare HamiltonHamilton, Ontario, CanadaNot Yet Recruiting
Kingston Health Sciences CentreKingston, Ontario, CanadaRecruiting
The Ottawa Hospital - General CampusOttawa, Ontario, CanadaNot Yet Recruiting
The Ottawa Hospital - Civic CampusOttawa, Ontario, CanadaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05829317